United States · FDA National Drug Code directory
Fingolimod
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62756-064_a0abec7c-e7a2-4bbf-936a-370e0eff4e9f
- Product NDC
- 62756-064
- Form
- CAPSULE
- Composition / generic term
- Fingolimod
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221025
- Source listing expiry
- 20261231
Source-listed ingredients
- FINGOLIMOD HYDROCHLORIDE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (62756-064-59) / 7 CAPSULE in 1 BLISTER PACK · 62756-064-59
- 90 CAPSULE in 1 BOTTLE (62756-064-81) · 62756-064-81
- 30 CAPSULE in 1 BOTTLE (62756-064-83) · 62756-064-83
- 2 BLISTER PACK in 1 CARTON (62756-064-96) / 14 CAPSULE in 1 BLISTER PACK · 62756-064-96
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →